Hudson Bay Capital Management LP Denali Therapeutics Inc. Transaction History
Hudson Bay Capital Management LP
- $21.9 Billion
- Q3 2024
A detailed history of Hudson Bay Capital Management LP transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 34,500 shares of DNLI stock, worth $803,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,500
Previous 175,000
80.29%
Holding current value
$803,850
Previous $4.06 Million
75.29%
% of portfolio
0.0%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding DNLI
# of Institutions
226Shares Held
119MCall Options Held
60.6KPut Options Held
48.4K-
Black Rock Inc. New York, NY13.2MShares$307 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$287 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$260 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$250 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.91MShares$184 Million0.05% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $3.13B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...